Literature DB >> 23380756

Clinical utility of natriuretic peptides in left ventricular failure.

Pramod Reddy1, Rohan Samson.   

Abstract

Left ventricular failure (LVF) is a clinical syndrome caused by abnormal systolic or diastolic function failing to meet the metabolic requirements of the body. It is important to diagnose and manage LVF in the earliest stages to prevent mortality and morbidity. This article extensively reviews the diagnostic, therapeutic, and prognostic utility of natriuretic peptides in LVF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380756     DOI: 10.1097/SMJ.0b013e3182804b66

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes.

Authors:  Seung-Jae Lee; Dong-Geun Lee; Dal-Soo Lim; Sukkeun Hong; Jin-Sik Park
Journal:  Dis Markers       Date:  2015-03-05       Impact factor: 3.434

2.  Prognostic utility of NT-proBNP greater than 70,000 pg/mL in patients with end stage renal disease.

Authors:  Julio Perez-Downes; Carlos Palacio; Saif Ibrahim; Patrisha Shelley; Alan Miller; Pramod Reddy
Journal:  J Geriatr Cardiol       Date:  2018-07       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.